Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Chemical structure of kaempferol (A), and epithelial mucus hypersecretion in trachea and lung tissues (B).

BALB/c mice were OVA-sensitized and orally supplemented with 10–20 mg/kg kaempferol. Lung tissue extracts were prepared for Western blot analysis with a primary antibody against MUC5AC. Representative blot data were obtained from 3 experiments, and β-actin protein was used as an internal control. The bar graphs (mean ± SEM) in the right panel represent quantitative results of blots. Values in bar graphs not sharing a letter indicate significant different at P<0.05. Tissue sections of mouse trachea and lung were stained by using PAS reagents and counterstained with hematoxylin (C and D). A strong PAS positive staining (red arrows) in many areas of mucous cells of airway epithelium was observed. Each photograph is representative of four mice.

More »

Fig 1 Expand

Fig 2.

Time course responses of MUC5AC induction to TGF-β and tunicamycin (A and C), and inhibition of MUC5AC induction by kaempferol (B and D).

BEAS-2B cells were treated with 10 ng/ml TGF-β or 1 μM tunicamycin up to 72 h in the absence and presence of 1–20 μM kaempferol. For the measurement of MUC5AC induction, total cell lysates were subject to Western blot analysis with a primary antibody against MUC5AC. β-Actin was used as an internal control. The bar graphs (mean ± SEM) in the bottom panels represent quantitative results of blots. Values not sharing a common letter are significantly different at P<0.05.

More »

Fig 2 Expand

Fig 3.

Inhibitory effects of kaempferol on tunicamycin-induced expression and activation of ATF6 and IRE1α (A), and GRP78 and HSP70 (B) in BEAS-2B cells.

Cells were treated with 1–20 μM kaempferol and simulated with 1 μM tunicamycin. Cell lysates were prepared for Western blot analysis with a primary antibody against ATF6, phospho-IRE1α, GRP78 and HSP70. Representative blot data were obtained from 3 experiments, and β-actin protein was used as an internal control. The bar graphs (mean ± SEM) in the bottom panels represent quantitative results of upper blots. Values in bar graphs not sharing a letter indicate significant different at P<0.05.

More »

Fig 3 Expand

Fig 4.

RT-PCR data showing XBP-1 mRNA splicing (A and B) and Western blot data showing XBP-1 induction (C) in tunicamycin-stimulated and kaempferol-supplemented BEAS-2B cells.

Cells were treated with 1–20 μM kaempferol and simulated with 1 μM tunicamycin. GAPDH was used as a housekeeping gene for the co-amplification with XBP-1 (A and B). Cell lysates were prepared for Western blot analysis with a primary antibody against XBP-1 (C). Representative blot data were obtained from 3 experiments, and β-actin protein was used as an internal control. The bar graphs (mean ± SEM) in the bottom panel represent quantitative results of upper blots. Values in bar graphs not sharing a letter indicate significant different at P<0.05.

More »

Fig 4 Expand

Fig 5.

Suppressive effects of kaempferol on induction and activation of SMAD4, IRE1α and GRP78 (A), and XBP-1 protein induction (B) and XBP-1 mRNA transcription and splicing (C and D) in TGF-β-stimulated BEAS-2B cells.

Cells were treated with 1–20 μM kaempferol and simulated with 10 ng/ml TGF-β. Cell lysates were prepared for Western blot analysis with a primary antibody against SMAD4, phospho-IRE1α, GRP78 and XBP-1. Representative blot data were obtained from 3 experiments, and β-actin protein was used as an internal control. The bar graphs (mean ± SEM) represent quantitative results of blots. Values in bar graphs not sharing a letter indicate significant different at P<0.05. RT-PCR was conducted to determine XBP-1 mRNA splicing (C and D). GAPDH was used as a housekeeping gene for the co-amplification with XBP-1.

More »

Fig 5 Expand

Fig 6.

Immunofluorescent data showing inhibition of XBP-1 induction in OVA-challenged mouse lung tissues by kaempferol.

Epithelial XBP-1 protein was identified as reddish and/or pinkish staining. XBP-1 was visualized with a Cy3-conjugated secondary antibody and nuclear staining was done with DAPI. Each photograph is representative of four mice. Magnification: 200-fold. The bar graphs (mean ± SEM) represent quantitative results of Cy3 staining. Values in bar graphs not sharing a letter indicate significant different at P<0.05.

More »

Fig 6 Expand

Fig 7.

Immunohistochemical staining showing inhibition of IRE1α activation in OVA-challenged mouse lung tissues by kaempferol.

Epithelial IRE1α was identified as brown staining and was visualized with DAB and the counter-staining was done with hematoxylin. Each photograph is representative of four mice. Magnification: 200-fold. The bar graphs (mean ± SEM) represent quantitative results of DAB staining. Values in bar graphs not sharing a letter indicate significant different at P<0.05.

More »

Fig 7 Expand

Fig 8.

Inhibition of JNK activation and TRAF2 induction in BEAS-2B cells treated with kaempferol and exposed to 1 μM tunicamycin (A) or 10 ng/ml TGF-β (B).

Cell extracts were subject to 12% SDS-PAGE and western blot analysis with a primary antibody against total JNK, phospho-JNK and TRAF2. β-Actin protein was used as an internal control. The bar graphs (mean ± SEM) in the bottom panels represent quantitative results of blots obtained from a densitometer. Values not sharing a common letter are significantly different at P<0.05. BALB/c mice were OVA-sensitized and orally supplemented with 10–20 mg/kg kaempferol (C). Epithelial TRAF2 was identified as reddish staining and was visualized with ACE and the counter-staining was done with hematoxylin. Each photograph is representative of four mice. Magnification: 200-fold.

More »

Fig 8 Expand

Fig 9.

Inhibition of XBP-1 mRNA splicing (A and B) and MUC5AC induction (C and D) by JNK inhibitor.

BEAS-2B cells were treated with kaempferol and exposed to 1 μM tunicamycin or 10 ng/ml TGF-β. RT-PCR was conducted to determine XBP-1 mRNA splicing (A and B). GAPDH was used as a housekeeping gene for the co-amplification with XBP-1. Cell extracts were subject to 12% SDS-PAGE and Western blot analysis with a primary antibody against MUC5AC. β-Actin protein was used as an internal control. The bar graphs (mean ± SEM) in the bottom panels represent quantitative results of blots obtained from a densitometer. Values not sharing a common letter are significantly different at P<0.05.

More »

Fig 9 Expand